Volume 52, Issue 3
Research Article

A Bayesian method to estimate the optimal threshold of a longitudinal biomarker

Fabien Subtil

Corresponding Author

E-mail address: fabien.subtil@chu‐lyon.fr

Université de Lyon, F‐69000, Lyon; Université Lyon 1; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, F‐69622, Villeurbanne, France

Hospices Civils de Lyon, Service de Biostatistique, F‐69003, Lyon, France

Phone: +33‐4‐7211‐5751, Fax: +33‐4‐7211‐5141Search for more papers by this author
Muriel Rabilloud

Université de Lyon, F‐69000, Lyon; Université Lyon 1; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, F‐69622, Villeurbanne, France

Hospices Civils de Lyon, Service de Biostatistique, F‐69003, Lyon, France

Search for more papers by this author
First published: 17 June 2010
Citations: 8

Abstract

The objective of this study was to develop methods to estimate the optimal threshold of a longitudinal biomarker and its credible interval when the diagnostic test is based on a criterion that reflects a dynamic progression of that biomarker. Two methods are proposed: one parametric and one non‐parametric. In both the cases, the Bayesian inference was used to derive the posterior distribution of the optimal threshold from which an estimate and a credible interval could be obtained. A numerical study shows that the bias of the parametric method is low and the coverage probability of the credible interval close to the nominal value, with a small coverage asymmetry in some cases. This is also true for the non‐parametric method in case of large sample sizes. Both the methods were applied to estimate the optimal prostate‐specific antigen nadir value to diagnose prostate cancer recurrence after a high‐intensity focused ultrasound treatment. The parametric method can also be applied to non‐longitudinal biomarkers.

Number of times cited according to CrossRef: 8

  • Optimal data-driven policies for disease screening under noisy biomarker measurement, IISE Transactions, 10.1080/24725854.2019.1630867, (1-15), (2019).
  • A Bayesian method to estimate the optimal threshold of a marker used to select patients' treatment, Statistical Methods in Medical Research, 10.1177/0962280218821394, (096228021882139), (2019).
  • Performance of the 4-mg intravenous dexamethasone suppression test in differentiating Cushing disease from pseudo-Cushing syndrome, Annales d'Endocrinologie, 10.1016/j.ando.2015.11.001, 77, 1, (30-36), (2016).
  • An enhancement of ROC curves made them clinically relevant for diagnostic-test comparison and optimal-threshold determination, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2015.01.003, 68, 7, (752-759), (2015).
  • Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions, BMC Medical Informatics and Decision Making, 10.1186/1472-6947-14-53, 14, 1, (2014).
  • Individual patient data systematic review and meta-analysis of optic nerve sheath diameter ultrasonography for detecting raised intracranial pressure: protocol of the ONSD research group, Systematic Reviews, 10.1186/2046-4053-2-62, 2, 1, (2013).
  • Multimarker Panels in Sepsis, Critical Care Clinics, 10.1016/j.ccc.2010.12.011, 27, 2, (391-405), (2011).
  • Comments on the article of C.-Y. Lai, L. Tian, and E.F. Schisterman on the “Exact confidence interval estimation for the Youden index and its corresponding optimal cut-point”, Computational Statistics & Data Analysis, 10.1016/j.csda.2011.05.022, 55, 12, (3379-3380), (2011).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.